Patents by Inventor Scott Barton
Scott Barton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20260062937Abstract: A construction material repair device designed for filling, repairing, and restoring defects in construction materials comprising right-handed female tapered helical thread to aid insertion and adhesively secured into the construction material to cosmetically repair and structurally restore the defect in minimal steps, time, and cost. The device is manufactured in a variety of materials to match or complement the construction material requiring repair.Type: ApplicationFiled: September 4, 2024Publication date: March 5, 2026Inventor: Scott Barton
-
Patent number: 12325000Abstract: Various examples are provided for water purification systems that employ filters, and more particularly to water purification systems that extend the life of such filters. In one example, the water purification system includes a valve that in an energized position allows the flow of unfiltered water through a filter assembly containing filters. A monitor is provided to detect whether the faucet has been moved to the closed position. In the event no movement of the faucet from the closed position is detected within a predefined time interval, then the valve is de-energized causing water flow to bypass the filter assembly, thus extending filter life. In another example, the water purification system provides a flow path having a straight-line geometry to provide for quieter water flow and reduces pressure drop.Type: GrantFiled: October 26, 2023Date of Patent: June 10, 2025Assignee: Environmental Solutions 4-Life, Inc.Inventor: Scott Barton
-
Publication number: 20250152818Abstract: An injection device includes a carrier, a needle, a driver coupled to the needle, the driver being slidable relative to the carrier between a retracted configuration and a deployed configuration, a shuttle configured to move the driver between the retracted configuration and the deployed configuration, and a stop configured to move from a first configuration to a second configuration, wherein the stop is configured to maintain the driver in the deployed configuration, and movement of the stop from the first configuration to the second configuration allows the shuttle to move the driver from the deployed configuration to the retracted configuration.Type: ApplicationFiled: January 14, 2025Publication date: May 15, 2025Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Bryan C. Grygus, Alfred MARINO, Rachel P. ARNOTT, Scott BARTON, Bart E. BURGESS, Richard GILDERSLEEVE, Alexei GORALTCHOUK, Daniel HALBIG, Christopher KANEL, Trevor LANGLEY
-
Publication number: 20250135380Abstract: Various examples are provided for water purification systems that employ filters, and more particularly to water purification systems that extend the life of such filters. In one example, the water purification system includes a valve that in an energized position allows the flow of unfiltered water through a filter assembly containing filters. A monitor is provided to detect whether the faucet has been moved to the closed position. In the event no movement of the faucet from the closed position is detected within a predefined time interval, then the valve is de-energized causing water flow to bypass the filter assembly, thus extending filter life. In another example, the water purification system provides a flow path having a straight-line geometry to provide for quieter water flow and reduces pressure drop.Type: ApplicationFiled: October 26, 2023Publication date: May 1, 2025Applicant: Environmental Solutions 4-Life, Inc. DBA CosanUSAInventor: Scott Barton
-
Patent number: 12226613Abstract: An injection device includes a carrier, a needle, a driver coupled to the needle, the driver being slidable relative to the carrier between a retracted configuration and a deployed configuration, a shuttle configured to move the driver between the retracted configuration and the deployed configuration, and a stop configured to move from a first configuration to a second configuration, wherein the stop is configured to maintain the driver in the deployed configuration, and movement of the stop from the first configuration to the second configuration allows the shuttle to move the driver from the deployed configuration to the retracted configuration.Type: GrantFiled: December 8, 2022Date of Patent: February 18, 2025Assignee: Regeneron Pharmaceuticals, Inc.Inventors: Bryan C. Grygus, Alfred Marino, Rachel P. Arnott, Scott Barton, Bart E. Burgess, Richard Gildersleeve, Alexei Goraltchouk, Daniel Halbig, Christopher Kanel, Trevor Langley
-
Publication number: 20230105585Abstract: An injection device includes a carrier, a needle, a driver coupled to the needle, the driver being slidable relative to the carrier between a retracted configuration and a deployed configuration, a shuttle configured to move the driver between the retracted configuration and the deployed configuration, and a stop configured to move from a first configuration to a second configuration, wherein the stop is configured to maintain the driver in the deployed configuration, and movement of the stop from the first configuration to the second configuration allows the shuttle to move the driver from the deployed configuration to the retracted configuration.Type: ApplicationFiled: December 8, 2022Publication date: April 6, 2023Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Bryan C. GRYGUS, Alfred MARINO, Rachel P. ARNOTT, Scott BARTON, Bart E. BURGESS, Richard GILDERSLEEVE, Alexei GORALTCHOUK, Daniel HALBIG, Christopher KANEL, Trevor LANGLEY
-
Publication number: 20230020306Abstract: The present disclosure relates to a therapeutic agent delivery device with anti-roll features. In one embodiment, a therapeutic agent delivery device may include a tubular body including a first end portion, a second end portion, and a lumen extending between the first end portion and the second portion. An outer surface of the tubular body includes a first opening in communication with the lumen. The outer surface of the tubular body further may include a ledge extending around a periphery of the first opening, and a portion of the ledge closest to the second end portion of the tubular body may be shaped as an arrowhead. The therapeutic agent delivery device also may include a cap configured to engage the second end portion of the tubular body, wherein the cap may include a central longitudinal axis, a first end having a first cross-sectional dimension, and a second end having a second cross-sectional dimension larger than the first cross-sectional dimension.Type: ApplicationFiled: September 23, 2022Publication date: January 19, 2023Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Courtney NICHOLAS, Scott BARTON, Bart E. BURGESS, Alexei GORALTCHOUK
-
Patent number: 11547801Abstract: An injection device includes a carrier, a needle, a driver coupled to the needle, the driver being slidable relative to the carrier between a retracted configuration and a deployed configuration, a shuttle configured to move the driver between the retracted configuration and the deployed configuration, and a stop configured to move from a first configuration to a second configuration, wherein the stop is configured to maintain the driver in the deployed configuration, and movement of the stop from the first configuration to the second configuration allows the shuttle to move the driver from the deployed configuration to the retracted configuration.Type: GrantFiled: May 4, 2018Date of Patent: January 10, 2023Assignee: REGENERON PHARMACEUTICALS, INC.Inventors: Bryan C. Grygus, Alfred Marino, Rachel P. Arnott, Scott Barton, Bart E. Burgess, Richard Gildersleeve, Alexei Goraltchouk, Daniel Halbig, Christopher Kanel, Trevor Langley
-
Patent number: 11484654Abstract: The present disclosure relates to a therapeutic agent delivery device with anti-roll features. In one embodiment, a therapeutic agent delivery device may include a tubular body including a first end portion, a second end portion, and a lumen extending between the first end portion and the second portion. An outer surface of the tubular body includes a first opening in communication with the lumen. The outer surface of the tubular body further may include a ledge extending around a periphery of the first opening, and a portion of the ledge closest to the second end portion of the tubular body may be shaped as an arrowhead. The therapeutic agent delivery device also may include a cap configured to engage the second end portion of the tubular body, which may include a curved sidewall extending radially outward. The curved sidewall may include a protrusion.Type: GrantFiled: June 29, 2018Date of Patent: November 1, 2022Assignee: Regeneron Pharmaceuticals, Inc.Inventors: Courtney Nicholas, Scott Barton, Bart E. Burgess, Alexei Goraltchouk
-
Publication number: 20200139050Abstract: The present disclosure relates to a therapeutic agent delivery device with anti-roll features. In one embodiment, a therapeutic agent delivery device may include a tubular body including a first end portion, a second end portion, and a lumen extending between the first end portion and the second portion. An outer surface of the tubular body includes a first opening in communication with the lumen. The outer surface of the tubular body further may include a ledge extending around a periphery of the first opening, and a portion of the ledge closest to the second end portion of the tubular body may be shaped as an arrowhead. The therapeutic agent delivery device also may include a cap configured to engage the second end portion of the tubular body, which may include a curved sidewall extending radially outward. The curved sidewall may include a protrusion.Type: ApplicationFiled: June 29, 2018Publication date: May 7, 2020Applicant: Regeneron Pharmaceuticals, Inc.Inventors: Courtney NICHOLAS, Scott BARTON, Bart E. BURGESS, Alexei GORALTCHOUK
-
Patent number: D892311Type: GrantFiled: April 25, 2018Date of Patent: August 4, 2020Assignee: Sanofi-Aventis Deutschland GMBHInventors: Courtney Nicholas, Scott Barton, Alex Zuyev, Alexei Goraltchouk, Bart Burgess
-
Patent number: D892312Type: GrantFiled: April 25, 2018Date of Patent: August 4, 2020Assignee: Sanofi-Aventis Deutschland GMBHInventors: Courtney Nicholas, Scott Barton, Bart Burgess, Alexei Goraltchouk
-
Patent number: D898191Type: GrantFiled: April 25, 2018Date of Patent: October 6, 2020Assignee: Sanofi-Aventis Deutschland GMBHInventors: Courtney Nicholas, Scott Barton, Bart Burgess, Alexei Goraltchouk
-
Patent number: D901008Type: GrantFiled: April 25, 2018Date of Patent: November 3, 2020Assignee: Sanofi-Aventis Deutschland GMBHInventors: Courtney Nicholas, Scott Barton, Bart Burgess, Alexei Goraltchouk, Alex Zuyev
-
Patent number: D903856Type: GrantFiled: June 29, 2018Date of Patent: December 1, 2020Assignee: Regeneron Pharmaceuticals, Inc.Inventors: Courtney Nicholas, Scott Barton, Bart Burgess, Alexei Goraltchouk, Alex Zuyev
-
Patent number: D908867Type: GrantFiled: April 25, 2018Date of Patent: January 26, 2021Assignees: Sanofi-Aventis Deutschland GMBH, Regeneron Pharmaceuticals, Inc.Inventors: Courtney Nicholas, Scott Barton, Bart Burgess, Alexei Goraltchouk
-
Patent number: D916277Type: GrantFiled: July 23, 2020Date of Patent: April 13, 2021Assignees: Sanofi-Aventis Deutschland GMBH, Regeneron Pharmaceuticals, Inc.Inventors: Courtney Nicholas, Scott Barton, Alex Zuyev, Bart Burgess, Alexei Goraltchouk
-
Patent number: D932006Type: GrantFiled: November 21, 2018Date of Patent: September 28, 2021Assignee: Regeneron Pharmaceuticals, Inc.Inventors: Courtney Nicholas, Scott Barton, Bart E. Burgess, Alexei Goraltchouk, Paige Waechter, Alex Zuyev
-
Patent number: D934413Type: GrantFiled: July 23, 2020Date of Patent: October 26, 2021Assignee: Sanofi-Aventis Deutschland GMBHInventors: Courtney Nicholas, Scott Barton, Bart Burgess, Alexei Goraltchouk
-
Patent number: D958973Type: GrantFiled: July 26, 2021Date of Patent: July 26, 2022Assignee: Regeneron Pharmaceuticals, Inc.Inventors: Courtney Nicholas, Scott Barton, Bart E. Burgess, Alexei Goraltchouk, Paige Waechter